BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 15118930)

  • 1. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A; Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical gene therapy studies for hemophilia using adenoviral vectors.
    Thorrez L; VandenDriessche T; Collen D; Chuah MK
    Semin Thromb Hemost; 2004 Apr; 30(2):173-83. PubMed ID: 15118929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonviral gene therapy approaches to hemophilia.
    Gómez-Vargas A; Hortelano G
    Semin Thromb Hemost; 2004 Apr; 30(2):197-204. PubMed ID: 15118931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for hemophilia.
    Chuah MK; Collen D; VandenDriessche T
    J Gene Med; 2001; 3(1):3-20. PubMed ID: 11269333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical animal models for hemophilia gene therapy: predictive value and limitations.
    Rawle FE; Lillicrap D
    Semin Thromb Hemost; 2004 Apr; 30(2):205-13. PubMed ID: 15118932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
    Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
    Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy strategies for hemophilia: benefits versus risks.
    Petrus I; Chuah M; VandenDriessche T
    J Gene Med; 2010 Oct; 12(10):797-809. PubMed ID: 20848668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
    Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
    Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical gene transfer studies for hemophilia A.
    Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):249-56. PubMed ID: 15118936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.
    Vandendriessche T; Thorrez L; Acosta-Sanchez A; Petrus I; Wang L; Ma L; DE Waele L; Iwasaki Y; Gillijns V; Wilson JM; Collen D; Chuah MK
    J Thromb Haemost; 2007 Jan; 5(1):16-24. PubMed ID: 17002653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for hemophilia: clinical trials and technical tribulations.
    Viiala NO; Larsen SR; Rasko JE
    Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for hemophilia.
    Ponder KP
    Curr Opin Hematol; 2006 Sep; 13(5):301-7. PubMed ID: 16888433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
    Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
    Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah M; Vandendriessche T
    Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ; He J
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune implications of gene therapy for hemophilia.
    Herzog RW; Dobrzynski E
    Semin Thromb Hemost; 2004 Apr; 30(2):215-26. PubMed ID: 15118933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells.
    Herder C; Tonn T; Oostendorp R; Becker S; Keller U; Peschel C; Grez M; Seifried E
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2266-72. PubMed ID: 14551158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.